Lineage Free Cash Flow Yield from 2010 to 2024

LCTX Stock  USD 0.61  0.04  7.02%   
Lineage Cell Free Cash Flow Yield yearly trend continues to be fairly stable with very little volatility. Free Cash Flow Yield will likely drop to -0.16 in 2024. Free Cash Flow Yield is a financial solvency ratio that compares the free cash flow per share Lineage Cell Therapeutics is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share. View All Fundamentals
 
Free Cash Flow Yield  
First Reported
2010-12-31
Previous Quarter
(0.16)
Current Value
(0.16)
Quarterly Volatility
0.07758464
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Lineage Cell financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Lineage Cell's main balance sheet or income statement drivers, such as Depreciation And Amortization of 922.5 K, Interest Expense of 6 M or Total Revenue of 9.4 M, as well as many indicators such as Price To Sales Ratio of 19.99, Dividend Yield of 0.0015 or PTB Ratio of 3.12. Lineage financial statements analysis is a perfect complement when working with Lineage Cell Valuation or Volatility modules.
  
Check out the analysis of Lineage Cell Correlation against competitors.

Latest Lineage Cell's Free Cash Flow Yield Growth Pattern

Below is the plot of the Free Cash Flow Yield of Lineage Cell Therapeutics over the last few years. It is a financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share. Lineage Cell's Free Cash Flow Yield historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Lineage Cell's overall financial position and show how it may be relating to other accounts over time.
Free Cash Flow Yield10 Years Trend
Very volatile
   Free Cash Flow Yield   
       Timeline  

Lineage Free Cash Flow Yield Regression Statistics

Arithmetic Mean(0.13)
Geometric Mean0.1
Coefficient Of Variation(59.52)
Mean Deviation0.06
Median(0.13)
Standard Deviation0.08
Sample Variance0.01
Range0.2991
R-Value(0.09)
Mean Square Error0.01
R-Squared0.01
Significance0.76
Slope(0)
Total Sum of Squares0.08

Lineage Free Cash Flow Yield History

2022 0.003252
2021 -0.0593
2020 -0.075
2019 -0.25
2018 -0.3
2015 -0.15

About Lineage Cell Financial Statements

Lineage Cell investors use historical fundamental indicators, such as Lineage Cell's Free Cash Flow Yield, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Lineage Cell. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Free Cash Flow Yield(0.16)(0.16)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Lineage Stock Analysis

When running Lineage Cell's price analysis, check to measure Lineage Cell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lineage Cell is operating at the current time. Most of Lineage Cell's value examination focuses on studying past and present price action to predict the probability of Lineage Cell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lineage Cell's price. Additionally, you may evaluate how the addition of Lineage Cell to your portfolios can decrease your overall portfolio volatility.